Richard Kho
Directeur Général chez Diagnose Early, Inc.
Postes actifs de Richard Kho
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Diagnose Early, Inc.
 Diagnose Early, Inc. Pharmaceuticals: MajorHealth Technology Diagnose Early, Inc. is a company that specializes in non-invasive breath and biometric testing. The company is based in Newark, CA. The company has developed a proprietary breath analysis technology and an AI health data platform that allows users to collect their health data in one place. The company's breath testing technology is designed to provide non-invasive detection of toxins and other chemicals that may pose a health threat in minutes. Diagnose Early was founded by Boris Fain, Chris Wheeler, and John Cunniff. Chris Wheeler has been the CEO since incorporation. | Directeur Général | 21/11/2023 | - |
Historique de carrière de Richard Kho
Anciens postes connus de Richard Kho
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Iterative Health, Inc.
 Iterative Health, Inc. Packaged SoftwareTechnology Services Iterative Scopes, Inc. develops machine learning-powered diagnostic tools for prevention of colon cancer. The company wad founded by Jonathan Ng in 2017 and is headquartered in Boston, MA. | Directeur/Membre du Conseil | 13/10/2021 | - |
| Directeur des opérations | 13/10/2021 | - |
Formation de Richard Kho
| University of Southern California | Masters Business Admin |
| University of California | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| Director/Board Member | 1 |
| Chief Operating Officer | 1 |
| Masters Business Admin | 1 |
Sectorielle
| Consumer Services | 3 |
| Technology Services | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Iterative Health, Inc.
Iterative Health, Inc. Packaged SoftwareTechnology Services Iterative Scopes, Inc. develops machine learning-powered diagnostic tools for prevention of colon cancer. The company wad founded by Jonathan Ng in 2017 and is headquartered in Boston, MA. | Technology Services |
Diagnose Early, Inc.
Diagnose Early, Inc. Pharmaceuticals: MajorHealth Technology Diagnose Early, Inc. is a company that specializes in non-invasive breath and biometric testing. The company is based in Newark, CA. The company has developed a proprietary breath analysis technology and an AI health data platform that allows users to collect their health data in one place. The company's breath testing technology is designed to provide non-invasive detection of toxins and other chemicals that may pose a health threat in minutes. Diagnose Early was founded by Boris Fain, Chris Wheeler, and John Cunniff. Chris Wheeler has been the CEO since incorporation. | Health Technology |
- Bourse
- Insiders
- Richard Kho
- Expérience
